Write in a clean editor, then format for Neurology Perspectives in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Neurology Perspectives is a peer-reviewed journal published by Elsevier, covering Medical research and treatments, Nursing care and research, Health and Medical Education.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Neurology Perspectives 12 (2023) 45–58.
Formats any DOI in Neurology Perspectives style. No sign-up. |
| Publishes research in | Medical research and treatments Nursing care and research Health and Medical Education Aging, Health, and Disability Health, Education, and Physical Culture |
| ISSN | 2667-0496 |
| Citation impact (2-yr) | 0.04 |
| h-index | 11 |
| i10-index | 16 |
| Total citations | 602 |
| Article processing charge | $1,480 |
| Open access | Yes |
| Top institutions publishing here | Biomedical Research Networking Center on Neurodegenerative Diseases |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
SARS-CoV-2 infection frequently causes neurological symptoms. Cognitive alterations are among the most frequent symptoms, and may persist beyond the acute phase of infection. We conducted a narrative review of the literature. Hospitalised patients, and especially critically ill patients, are at greater risk of developing cognitive symptoms. Post–COVID-19 cognitive symptoms, unlike those associated with other viral…
Deep brain stimulation (DBS) is a surgical procedure used to treat various neurological pathologies, being its greatest use in movement disorders. The FDA first approved deep brain stimulation in 1997 to treat essential tremor, in 2002 it was approved for Parkinson's disease, in 2003 for dystonia and in 2009 for obsessive compulsive disorder. However, until…
SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. The acute infection is characterised not only by respiratory symptoms, but also by multiple systemic manifestations, including neurological symptoms. Among these, headache is a frequent complaint. As the pandemic progresses and the population of patients recovering from COVID-19 grows, it is becoming apparent that the headache…
Post-COVID-19 syndrome is a series of chronic signs and symptoms that may appear after SARS-CoV-2 infection, including fatigue, dyspnoea, chest pain, palpitations, anxiety, depression, and joint and muscle pain. The purpose of this study was to review the controversies on post-COVID-19 syndrome, the frequency of neurological symptoms, and the potential pathophysiological mechanisms. We present a…
Parkinson's disease (PD) accounts for a significant burden on modern society, with an increasingly rapid growth in cases. Variants of several genes have been linked to the risk of developing the disease (e.g., the GBA gene). Other genes have been associated with autosomal dominant (e.g., SNCA, LRRK2, VPS35) and autosomal recessive PD (e.g., PRKN, PINK1,…
